Different expression of nm23-H1 and nm23-H2 protein with proliferative activities in various sizes of human renal cell carcinoma

Oncology (Switzerland)

Volumn 53, Issue 1, 1996, Pages 79-87

  Hiasa, Yoshio ^a   Konishi, Noboru ^a   Tao, Ming ^a   Matsuda, Hirofumi ^a   Tsumatani, Ken Ichi ^a   Nakamura, Yoshiyuki ^a   Kitahori, Yoshiteru ^a   Ozono, Seiichiro ^a   Hirao, Yoshiyuki ^a   Okajima, Eigoro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Human; Nm23 H1; Nm23 H2; Proliferating cell nuclear antigen; Renal cell carcinoma; Silver binding nucleolar organizer regions

Indexed keywords

CYCLINE; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CHROMOSOME NOR; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; METASTASIS POTENTIAL; ONCOGENE; PRIORITY JOURNAL; TUMOR VOLUME;

CARCINOMA, RENAL CELL; CELL DIVISION; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MONOMERIC GTP-BINDING PROTEINS; NUCLEOLUS ORGANIZER REGION; NUCLEOSIDE-DIPHOSPHATE KINASE; PROLIFERATING CELL NUCLEAR ANTIGEN; TRANSCRIPTION FACTORS;

EID: 0030047166     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227540     Document Type: Article

References (42)

1. Skinner DG, Colvin RB, Vermilion CD, Pfister RC, Leadbetler WF: Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 1971: 28:1165-1170.
2. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameter in renal cell carcinoma. Am J Surg Pathol 1982:6:665-668.
3. Boxer RJ, Waisman J, Lieber MM, Mampaso FM, Skinner DG: Renal cell carcinoma: Computer analysis of 96 patients treated by nephrectomy. J Urol 1979:122:598-601.
4. Dcrcnzini M, Romagnoli T, Mingazzini P, Marinozzi V: Interphase nucleolar organizer region distribution as a diagnostic parameter to differentiate benign from malignant epithelial tumors of human intestine. Virchows Arch B Cell Pathol 1988:54:334.
5. Smith R, Crocker J: Evaluation of nucleolar region-associated proteins in breast malignancy. Histopathology associated proteins in breast malignancy. Histopathology 1988:12: 113-125.
6. Crocker J: Nucleolar organizer regions; in Underwood JCE (ed): Pathology of the Nucleus. London. Springer. 1990, pp 91-143.
7. Walker KA: The histopathological evaluation of nucleolar organizer region proteins. Commentary. Histopathology 1988:12:221-223.
8. Delahunt B, Bethwaite PB, Nacey JN, Ribas JL: Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: Comparison with tumor grade, mitotic index, and silver-staining nucleolar organizer region numbers. J Pathol 1993:170: 471-477.
9. Miyachi K, Fritzler MJ, Tan EM: Autoantibo-dv to a nuclear antibody in proliferating cells. J Immunol 1978;121:2228-2234.
10. Hall PA, Crocker J, Watts A, Slansfeld AG: A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathology 1988; 12:373-381.
11. Wilkins BS, Harris S, Waseem NH, Lanes DP, Jones DB: A study of cell proliferation in formalin-fixed, wax-embedded bone marrow trephine biopsis using the monoclonal antibody PC10, reactive with proliferating cell nuclear antigen (PCNA). J Pathol 1992:166:45-52.
12. Theunissen PHMH, Leers MPG, Bollen ECM: Proliferating cell nuclear antigen (PCNA) expression in formalin-fixed tissue of non-small cell lung carcinoma. Histopathology 1992:20: 251-255.
13. Parks RE, Agarwal RP: Nucleoside diphospho-kinase: in Boyer PD (ed): The Enzymes. New York. Academic Press. 1973. Vol 8. Pp 307-333.
14. Nickerson JA, Wells WW: The microtubule-associated nucleoside diphosphate kinase. J Biol Chem 1984:259:11297-11304.
15. Liotta LA, Steeg PS: Clues to the function of iir»23 and protein in development, signal transduction and tumor metastasis provided by studies of Dictyostelium discoideiun. J Natl Cancer Inst 1990;82:1170-1172.
16. Kimura N, Shimada N: Membrane-associated nucleolar diphosphate kinase from rat liver. J Biol Chem 1988;263:4647-4653.
17. Kimura N, Shimada N, Nomura K, Watanabc K: Isolation and characterization of a cDNA clone encoding rat nucleoside diphosphate kinase. J Biol Chem 1990:265:15744-15749.
18. Gilles AM, Presecan E, Vonica A, Lascu I: Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for hetero-genicity of hexamcric enzyme. J Biol Chem 1991;266:8784-8789.
19. Urano T, Fushida S, Furukawa K, Shiku H: Human inn23-H1 and H2 proteins have similar nucleoside diphosphate kinase activities. Int J Oncol 1992:1:425-430.
20. Stahl JA, Leone A, Rosengard AM, Porter L, King CH, Steeg PS: Identification of a second human inn23 gene. tim23-H2. Cancer Res 1991:51:445-449.
21. Bevilacqua G, Sobel ME, Liotta JA, Steeg PS: Association of low nm23 RNA levels in human primary infiltrating duct breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 1989;49:5185-5190.
22. Hennesv C, Henry JA, May FEB, Westley BR, Angus B, Lennard TWJ: Expression of the antimetastatic gene inn23 in human breast cancer: An association with good prognosis. J Natl Cancer Inst 1991:83:281-285.
23. Hirayama R, Sawai S, Takagi Y, Mishima Y, Kimura N, Shimada N, Esaki Y, Kurashima C, Utsuyama M, Hirokawa K: Positive relationship between expression of diphosphate (kinase) and good prognosis in human breast cancer. J Natl Cancer Inst 1991:83:1249-1520.
24. Nakayanta T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii N, Kimura N, Nagataki S: Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the lira 23 gene product. J Natl Cancer Inst 1992:84:1349-1354.
25. Konishi N, Nakaoka S, Tsuzuki T, Matsumoto K, Kitahori Y, Hiasa Y, Urano T, Shiku H: Expression of «i»23-H I and iwi23-H2 protein in prostate carcinoma. Jpn J Cancer Res 1993: 84:1050-1054.
26. Steeg PS, Bevilacqua G, Kopper L, Thorgeirs-son UP, Talmadgc JE, Liotta A, Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988:80:200-204.
27. Liotta LA, Steeg PS, Stetler-Stevevson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991:64:327-336.
28. Guinan PD, Vogelzang NJ, Fremgen AM, Chmiei JS, Sylvester JL, Setter SF, Imperato JP: Renal cell carcinoma: Tumor size, stage and survival. J Urol 1994:153:901-903.
29. Japanese Urological Association. The Japanese Society of Pathology and Japan Radiological Society: General Rules for Clinical and Pathological Studies on Renal Cell Carcinomas, ed 2. Tokyo. Kanehara Shuppan. 1992.
30. Ploton D, Menager M, Jeaesson P, Hintber G, Pigeon F, Adnet JJ: Improvement in the staining and the visualization of argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986;18:5-14.
31. Strohmeyer T, Ackerntann R: Classic and modern prognostic indicators in renal cell carcinoma. Urol Int 1991:47:203-212.
32. Delahunt B, Ribas JL, Nacey JN, Bethwaite PB: Nucleolar organizer regions and prognosis in renal cell carcinoma. J Pathol 1991:163:31-37.
33. Yang AH, Wang TY, Liu HC: Comparative study of the prognostic value of nuclear organizer regions in renal cell carcinomas. J Pathol 1992;166:157-161.
34. Bryan RL, Crocker J, Farr A: Nucleolar organiser region in kidney tumors and xanthogranulomatous pyelonephritis. J Clin Pathol 1990; 43:147-148.
35. Bravo R, MacDonald-Bravo H: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 1987; 105:1549-1554.
36. Rosengard AM, Krutzsch HC, Sheam A, Biggs JR, Barker E, Marguleis IMK, King CR, Liotta LA, Steeg PS: Reduced wn23/awd protein in tumor metastasis and aberrant Drosophila development. Nature 1989:342:177-180.
37. Barnes R, Masood S, Barker E, Rosengard AM, Coggin DL, Crowell T, Litta LA, Steeg PS: Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am J Pathol 1991; 139:245-250.
38. Cohn KH, Wang F, Desoto-Lapaix F, Solomon W, Patterson LG, Arnold MR, Weimar J. Feldman JG, Levy AT, Leone A, Stceg PS: Association of nm23-H I allelic deletions with distant métastasés in colorectal carcinomas. Lancet 1991;338:722-724.
39. Haut M, Steeg PS, Willson JKV, Markowitz SD: Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 1991;83:712-716.
40. Higashiyama M, Doi O, Yokouchi H, Kodarna K, Nakamori S, Tatcishi R, Kimura N: Immu-nokistochemical analysis of nm23 gene products DP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value. Br J Cancer 1992;66:533-536.
41. Hailat N, Kein DR, Mclhem RF, Zhu X, Eckerskom C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, Hanash SM: High levels of p19/m23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 1991;88:341-345.
42. Hiasa Y, Kitamura M, Nakaoka S, Ohshima M, Konishi N, Katahori Y, Hirao K, Fukushi-rna Y, Tho Y, Hayashi I, Ichijima K: Antigen immunohistochemistry of renal cell adenomas in autopsy cases: Relevance to histogenesis. Oncology 1995;52:97-105.